139 related articles for article (PubMed ID: 22450850)
21. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
22. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
Riediger T; Bothe C; Becskei C; Lutz TA
Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
[TBL] [Abstract][Full Text] [Related]
23. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data.
Nadler EP; Youn HA; Ren CJ; Fielding GA
J Pediatr Surg; 2008 Jan; 43(1):141-6. PubMed ID: 18206472
[TBL] [Abstract][Full Text] [Related]
24. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Spector D; Shikora S
Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
[TBL] [Abstract][Full Text] [Related]
25. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
Ballantyne GH
Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
[TBL] [Abstract][Full Text] [Related]
26. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
[TBL] [Abstract][Full Text] [Related]
27. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
28. Improvement in health-related quality of life in first year after laparoscopic adjustable gastric banding.
Pilone V; Mozzi E; Schettino AM; Furbetta F; Di Maro A; Giardiello C; Battistoni M; Gardinazzi A; Micheletto G; Perrotta N; Busetto L;
Surg Obes Relat Dis; 2012; 8(3):260-8. PubMed ID: 22398112
[TBL] [Abstract][Full Text] [Related]
29. Impaired postprandial releases/syntheses of ghrelin and PYY(3-36) and blunted responses to exogenous ghrelin and PYY(3-36) in a rodent model of diet-induced obesity.
Xu J; McNearney TA; Chen JD
J Gastroenterol Hepatol; 2011 Apr; 26(4):700-5. PubMed ID: 21054519
[TBL] [Abstract][Full Text] [Related]
30. Appetite-related peptides in childhood and adolescence: role of ghrelin, PYY, and GLP-1.
Horner K; Lee S
Appl Physiol Nutr Metab; 2015 Nov; 40(11):1089-99. PubMed ID: 26466085
[TBL] [Abstract][Full Text] [Related]
31. Reasons and outcomes of laparoscopic revisional surgery after laparoscopic adjustable gastric banding for morbid obesity.
Patel S; Eckstein J; Acholonu E; Abu-Jaish W; Szomstein S; Rosenthal RJ
Surg Obes Relat Dis; 2010; 6(4):391-8. PubMed ID: 20655021
[TBL] [Abstract][Full Text] [Related]
32. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
[TBL] [Abstract][Full Text] [Related]
33. CCK, PYY and PP: the control of energy balance.
Simpson K; Parker J; Plumer J; Bloom S
Handb Exp Pharmacol; 2012; (209):209-30. PubMed ID: 22249816
[TBL] [Abstract][Full Text] [Related]
34. Short-term oral oleoyl-estrone decreases the expression of ghrelin in the rat stomach.
Ferrer-Lorente R; Fernández-López JA; Alemany M; Cabot C
Regul Pept; 2009 Jan; 152(1-3):79-81. PubMed ID: 18848587
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.
Kirchner H; Tong J; Tschöp MH; Pfluger PT
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E909-19. PubMed ID: 20179246
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of adjustable gastric banding in a cohort of 186 super-obese patients with a BMI≥ 50 kg/m2.
Arapis K; Chosidow D; Lehmann M; Bado A; Polanco M; Kamoun-Zana S; Pelletier AL; Kousouri M; Marmuse JP
J Visc Surg; 2012 Apr; 149(2):e143-52. PubMed ID: 22386891
[TBL] [Abstract][Full Text] [Related]
37. Gut hormones: a weight off your mind.
Gardiner JV; Jayasena CN; Bloom SR
J Neuroendocrinol; 2008 Jun; 20(6):834-41. PubMed ID: 18601707
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of a randomized clinical trial comparing Roux-en-Y gastric bypass with vertical banded gastroplasty.
Werling M; Fändriks L; Björklund P; Maleckas A; Brandberg J; Lönroth H; le Roux CW; Olbers T
Br J Surg; 2013 Jan; 100(2):222-30. PubMed ID: 23180572
[TBL] [Abstract][Full Text] [Related]
39. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus.
Frühbeck G; Diez-Caballero A; Gil MJ; Montero I; Gómez-Ambrosi J; Salvador J; Cienfuegos JA
Obes Surg; 2004 May; 14(5):606-12. PubMed ID: 15186626
[TBL] [Abstract][Full Text] [Related]
40. The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
Wynne K; Bloom SR
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):612-20. PubMed ID: 17082808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
